Michelle M. Cummins

Capecitabine, Bevacizumab, and Mitomycin in First-Line Treatment of Metastatic Colorectal Cancer: Results of the Australasian Gastrointestinal Trials Group Randomized Phase III MAX Study

Niall C. Tebbutt, Kate Wilson, Val Gebski et al. · Journal of Clinical Oncology · 2010 · 417 citations · Full text

Medicine, Oncology, Pharmacology +11

Impact of <i>KRAS</i> and <i>BRAF</i> Gene Mutation Status on Outcomes From the Phase III AGITG MAX Trial of Capecitabine Alone or in Combination With Bevacizumab and Mitomycin in Advanced Colorectal Cancer

Timothy Price, Jennifer E. Hardingham, Chee Khoon Lee et al. · Journal of Clinical Oncology · 2011 · 210 citations · Full text

Medicine, Oncology, Pharmacology +17

Clinical activity of durvalumab for patients with advanced mismatch repair-deficient and repair-proficient endometrial cancer. A nonrandomized phase 2 clinical trial

Yoland Antill, Peey‐Sei Kok, Kristy Robledo et al. · Journal for ImmunoTherapy of Cancer · 2021 · 129 citations · Full text

Medicine, Gynecology, Oncology +13

Randomised, non-comparative phase II study of weekly docetaxel with cisplatin and 5-fluorouracil or with capecitabine in oesophagogastric cancer: the AGITG ATTAX trial

Niall C. Tebbutt, Michelle M. Cummins, T. Sourjina et al. · British Journal of Cancer · 2010 · 112 citations · Full text

Medicine, Oncology, Pharmacology +17

Vocal fold paresis

James A. Koufman, Gregory N. Postma, Michelle M. Cummins et al. · Otolaryngology · 2000 · 110 citations

Medicine, Otolaryngology, Speech-language Pathology +17